Nemera is a global medical device company focused on the design, development, and manufacture of drug-delivery systems and combination product components for pharmaceutical and biotechnology customers. Its portfolio covers parenteral delivery (pen and auto-injectors, prefilled syringe and vial safety systems), ophthalmic droppers and multi-dose systems, pulmonary and nasal inhalation devices, and dermal/topical applicators.
The company provides end-to-end industrial capabilities spanning human factors and device engineering, materials and polymer processing, precision injection molding, tooling, clean-room and automated assembly, testing, and lifecycle support. Production is conducted under medical-device quality and regulatory frameworks such as ISO 13485 and applicable GMP requirements. Nemera supplies platforms and customized solutions used across chronic and acute therapies, serving both originator and generic medicines.
None yet. When a new project in the record names Nemera as owner, partner or investor, it shows here.
Nemera's new pen injector uses Bormed™ PP for safety, sustainability, and high-volume production, reducing carbon footprint by 20% and enhancing usability with color-coded features.
